M&A

News

Liva buys Momenta to bolster digital health platform

Liva Healthcare has acquired Momenta to create one of the largest providers of digital healthy lifestyle services to the NHS in England.

News

Troubled 23andMe is exploring a sale of the business

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company.

News

Sage rejects Biogen takeover and launches review

Sage Therapeutics has unanimously rejected Biogen's acquisition offer of around $469 million, saying it "significantly undervalues" the company.

R&D

5 takeaways from JP Morgan 2025

I’m back from another week in San Francisco, where as usual I heard from experts and prognosticators about their expectations for the coming year in biotech.

News

Sun Pharma, Taro Pharma, and Antibe Therapeutics logos

Sun Pharma unit poised to buy Canadian biotech Antibe

Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer of drugs for pain and inflammation.

News

Sage sues Biogen after unsolicited takeover bid

Sage Therapeutics has left its view of Biogen's recent takeover bid in little doubt – it has just filed a lawsuit seeking to block the deal.

Liva buys Momenta to bolster digital health platform

Troubled 23andMe is exploring a sale of the business

Sage rejects Biogen takeover and launches review

5 takeaways from JP Morgan 2025

Sun Pharma unit poised to buy Canadian biotech Antibe

Sage sues Biogen after unsolicited takeover bid

ADARx, Trex, and Retension take aim at IPOs

Discover a new era of healthcare panel engagement: Grounded ...

M&A

Editor's Picks